跳至主要内容
临床试验/NCT01575678
NCT01575678Unknown2 期

The Effect of Melatonin on Nocturnal Enuresis

University of Aarhus1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2012年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
40
试验地点
1
主要终点
number of incontinence episodes

研究概览

简要总结

Aim: To investigate the effect of melatonin in bedwetting.

详细描述

Design: Double blind randomized placebocontrolled trial using crossover.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Years 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Monosymptomatic nocturnal enuresis
  • Age 6-14 years
  • Clinical examination normal
  • ≥ 3 wet nights / week due to either nocturnal polyuria with normal bladder size or reduced functional bladder capacity with normal urine output

排除标准

  • Constipation (by ROME III criteria)
  • Day incontinence
  • Overactive bladder (ICCS 2008 classification of symptoms)
  • Current or past history of clinical or laboratory findings that can be related to diseases or - conditions (eg pregnancy) likely to change the parameters examined, especially diseases of the kidney and urinary tract, liver or endocrine disorder.
  • Clinical signs of urinary tract infection
  • Hypertension, blood pressure assessed by ambulatory measurement with blood pressure cuff
  • Set treatment with one or more drugs

研究组 & 干预措施

Melatonin

Active Comparator

干预措施: Melatonin (Drug)

Lactose

Placebo Comparator

干预措施: Lactose (Drug)

结局指标

主要结局

number of incontinence episodes

时间窗: 10 weeks

次要结局

  • nocturnal blood pressure(4 weeks)
  • activity level(4 weeks)
  • bladder capacity(4 weeks)
  • nocturnal urine production(4 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验